Clinical and histological features of head and neck melanoma: A population-based study in France

British Journal of Dermatology

Volumn 172, Issue 3, 2015, Pages 707-715

  Dabouz, F ^a   Barbe, C ^b   Lesage, C ^a   Le Clainche, A ^b   Arnoult, G ^c   Hibon, E ^d   Bernard, P ^a   Grange, F ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL MAISON BLANCHE   (France)

^d Centre de Regroupement Informatique des Statistiques Anatomo pathologiques de Champagne Ardenne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARM; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; FRANCE; HEAD AND NECK CANCER; HEAD AND NECK MELANOMA; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SUN EXPOSURE; TUMOR LOCALIZATION; TUMOR VOLUME; ADOLESCENT; ADULT; HEAD AND NECK NEOPLASMS; MELANOMA; MIDDLE AGED; PATHOLOGY; SKIN NEOPLASMS; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84925306330     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13489     Document Type: Article

References (50)

1. Garbe C, Leiter U,. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
2. Arnold M, Holterhues C, Hollestein LM, et al,. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol 2014; 28: 1170-8.
3. Montella A, Gavin A, Middleton R, et al,. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Eur J Cancer 2009; 45: 2360-6.
4. Grange F,. [ Epidemiology of cutaneous melanoma: descriptive data in France and Europe ]. Ann Dermatol Venereol 2005; 132: 975-82 (in French).
5. Gillgren P, Månsson-Brahme E, Frisell J, et al,. A prospective population-based study of cutaneous malignant melanoma of the head and neck. Laryngoscope 2000; 110: 1498-504.
6. Garbe C, Büttner P, Bertz J, et al,. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995; 75: 2484-91.
7. Gillgren P, Månsson-Brahme E, Frisell J, et al,. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck-a population-based study. Acta Oncol Stockh Swed 1999; 38: 1069-74.
8. Golger A, Young DS, Ghazarian D, Neligan PC,. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study. Arch Otolaryngol Head Neck Surg 2007; 133: 442-7.
9. Juzeniene A, Micu E, Porojnicu AC, Moan J,. Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway. J Eur Acad Dermatol Venereol 2012; 26: 821-7.
10. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE,. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol 2008; 144: 515-21.
11. Lipsker D, Engel F, Cribier B, et al,. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007; 157: 338-43.
12. Lesage C, Barbe C, Le Clainche A, et al,. Sex-related location of head and neck melanoma strongly argues for a major role of sun exposure in cars and photoprotection by hair. J Invest Dermatol 2013; 133: 1205-11.
13. Ringborg U, Afzelius LE, Lagerlöf B, et al,. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer 1993; 71: 751-8.
14. De Giorgi V, Rossari S, Gori A, et al,. The prognostic impact of the anatomical sites in the 'head and neck melanoma': scalp versus face and neck. Melanoma Res 2012; 22: 402-5.
15. Hoersch B, Leiter U, Garbe C,. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol 2006; 155: 771-7.
16. Cox NH, Aitchison TC, MacKie RM,. Extrafacial lentigo maligna melanoma: analysis of 71 cases and comparison with lentigo maligna melanoma of the head and neck. Br J Dermatol 1998; 139: 439-43.
17. Barbe C, Hibon E, Vitry F, et al,. Clinical and pathological characteristics of melanoma: a population-based study in a French regional population. J Eur Acad Dermatol Venereol 2012; 26: 159-64.
18. Komisarovas L, Jayasinghe C, Seah TE, Ilankovan V,. Retrospective study on the cutaneous head and neck melanoma in Dorset (UK). Br J Oral Maxillofac Surg 2011; 49: 359-63.
19. Institut national de la statistique et des études économiques. Champagne-Ardenne. Available at: http://www.insee.fr/fr/regions/champagne-Ardenne/ (last accessed 25 January 2015) (in French).
20. Cubitt JJ, Khan AA, Royston E, et al,. Melanoma in Buckinghamshire: data from the inception of the skin cancer multidisciplinary team. J Skin Cancer 2013; 2013: 843282.
21. Ciocan D, Barbe C, Aubin F, et al,. Distinctive features of melanoma and its management in elderly patients: a population-based study in France. JAMA Dermatol 2013; 149: 1150-7.
22. Tseng WH, Martinez SR,. Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res 2011; 167: 192-8.
23. Siskind V, Whiteman DC, Aitken JF, et al,. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia). Cancer Causes Control 2005; 16: 193-9.
24. MacKie RM, Bray C, Vestey J, et al,. Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer 2007; 96: 1772-7.
25. Whiteman DC, Stickley M, Watt P, et al,. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 2006; 24: 3172-7.
26. Caini S, Gandini S, Sera F, et al,. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009; 45: 3054-63.
27. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
28. Newton-Bishop JA, Chang Y-M, Elliott F, et al,. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer 2011; 47: 732-41.
29. Whiteman DC, Bray CA, Siskind V, et al,. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982-2001. Cancer Causes Control 2007; 18: 485-91.
30. Liu W, Dowling JP, Murray WK, et al,. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142: 1551-8.
31. Kalkhoran S, Milne O, Zalaudek I, et al,. Historical, clinical, and dermoscopic characteristics of thin nodular melanoma. Arch Dermatol 2010; 146: 311-18.
32. Mar V, Roberts H, Wolfe R, et al,. Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. J Am Acad Dermatol 2013; 68: 568-75.
33. Grange F, Barbe C, Aubin F, et al,. Clinical and sociodemographic characteristics associated with thick melanomas: a population-based, case-case study in France. Arch Dermatol 2012; 148: 1370-6.
34. Osborne JE, Hutchinson PE,. Clinical correlates of Breslow thickness of malignant melanoma. Br J Dermatol 2001; 144: 476-83.
35. Levi F, Randimbison L, La Vecchia C, et al,. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer 1998; 78: 315-19.
36. Thörn M, Adami HO, Ringborg U, et al,. The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry. Eur J Cancer Clin Oncol 1989; 25: 483-91.
37. Macdonald JB, Dueck AC, Gray RJ, et al,. Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer 2011; 2: 538-43.
38. Kruijff S, Bastiaannet E, Francken AB, et al,. Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients. Br J Cancer 2012; 107: 570-4.
39. Balch CM, Soong SJ, Gershenwald JE, et al,. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-34.
40. Lin D, Franc BL, Kashani-Sabet M, Singer MI,. Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck 2006; 28: 249-55.
41. Daryanani D, Plukker JT, de Jong MA, et al,. Increased incidence of brain metastases in cutaneous head and neck melanoma. Melanoma Res 2005; 15: 119-24.
42. Grange F, Vitry F, Granel-Brocard F, et al,. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Arch Dermatol 2008; 144: 629-36.
43. Albertini JG, Countryman NB,. Delayed treatment and inadequate surgical margins for invasive melanoma in elderly patients. JAMA Dermatol 2013; 149: 1158.
44. Grange F, Maubec E, Barbe C, et al,. Sentinel lymph node biopsy or nodal observation in melanoma: a prospective study of patient choices. Dermatol Surg 2011; 37: 199-206.
45. Moehrle M, Soballa M, Korn M,. UV exposure in cars. Photodermatol Photoimmunol Photomed 2003; 19: 175-81.
46. Poynter JN, Elder JT, Fullen DR, et al,. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 2006; 16: 267-73.
47. Liu W, Kelly JW, Trivett M, et al,. Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. J Invest Dermatol 2007; 127: 900-5.
48. Curtin JA, Fridlyand J, Kageshita T, et al,. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-47.
49. Lee J-H, Choi J-W, Kim Y-S,. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol 2011; 164: 776-84.
50. Institut national de la statistique et des études économiques. [ The population in 2030 in Champagne-Ardenne region: a more marked aging than elsewhere ]. Available at: http://www.insee.fr/fr/themes/document.asp?ref-id=11612 (last accessed 25 January 2015) (in French).